chr6-29673174-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001109809.5(ZFP57):āc.937A>Gā(p.Arg313Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,613,002 control chromosomes in the GnomAD database, including 168 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001109809.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZFP57 | NM_001109809.5 | c.937A>G | p.Arg313Gly | missense_variant | 5/5 | ENST00000376883.2 | |
ZFP57 | NM_001366333.2 | c.721A>G | p.Arg241Gly | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZFP57 | ENST00000376883.2 | c.937A>G | p.Arg313Gly | missense_variant | 5/5 | 5 | NM_001109809.5 | P1 | |
ZFP57 | ENST00000488757.6 | c.721A>G | p.Arg241Gly | missense_variant | 4/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00962 AC: 1464AN: 152114Hom.: 15 Cov.: 32
GnomAD3 exomes AF: 0.0108 AC: 2641AN: 244622Hom.: 24 AF XY: 0.0111 AC XY: 1487AN XY: 133892
GnomAD4 exome AF: 0.0125 AC: 18199AN: 1460770Hom.: 153 Cov.: 31 AF XY: 0.0122 AC XY: 8894AN XY: 726702
GnomAD4 genome AF: 0.00962 AC: 1465AN: 152232Hom.: 15 Cov.: 32 AF XY: 0.00919 AC XY: 684AN XY: 74440
ClinVar
Submissions by phenotype
Diabetes mellitus, transient neonatal, 1 Benign:2
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 09, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Nov 21, 2018 | ACMG criteria: BP4 (8 predictors, REVEL 0.024), BS1 (1.7% in ExAC European pop.), BS2 (27 homozygotes in gnomAD)= benign - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at